Literature DB >> 32297144

A novel minimal-contact biomotion method for long-term respiratory rate monitoring.

Sarah Dietz-Terjung1,2,3, Jan Geldmacher4, Sebastian Brato4, Carolin-Maria Linker5,6, Matthias Welsner5, Christoph Schöbel5,7, Christian Taube5, Jürgen Götze6, Gerhard Weinreich5.   

Abstract

PURPOSE: In this study, we assessed the diagnostic accuracy of the device VitaLog (SWG Sportwerk GmbH & Co. KG, Dortmund, Germany) for estimation of respiratory rate (RR) variability.
METHODS: VitaLog is a minimal-contact biomotion device that is placed under the mattress topper. It senses respiratory effort and body movement using a piezoelectric sensor. Diagnostic accuracy was determined in 103 patients referred to our sleep laboratory for suspected sleep-disordered breathing (SDB). SDB was defined by AHI ≥ 15/h. Results provided by VitaLog were compared with nasal flow measurement obtained by polysomnography (PSG).
RESULTS: Diagnostic accuracy of VitaLog was excellent. We obtained a correlation of r = 0.99 and a bias of 0.2 cycles per minute (cpm) between VitaLog and PSG-provided nasal flow. Detection RR variability worked nearly identically in patients with and without SDB.
CONCLUSION: VitaLog is an appropriate method for determination of RR variability based on a minimal-contact biomotion sensor. This device is easy to handle, available at low cost, and suitable for long-term monitoring in the hospital or at home.

Entities:  

Keywords:  E-health; Minimal-contact device; Respiratory rate; Sleep disordered breathing; Telemonitoring

Year:  2020        PMID: 32297144     DOI: 10.1007/s11325-020-02067-4

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  1 in total

1.  Investigation of respiratory rate in patients with cystic fibrosis using a minimal-impact biomotion system.

Authors:  Svenja Straßburg; Carolin-Maria Linker; Sebastian Brato; Christoph Schöbel; Christian Taube; Jürgen Götze; Florian Stehling; Sivagurunathan Sutharsan; Matthias Welsner; Gerhard Weinreich
Journal:  BMC Pulm Med       Date:  2022-02-11       Impact factor: 3.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.